Showing results (401-410 of 921) with videos related to

Sort By:
Pageof 93
Journal of Crohn'S & Colitis|June 30, 2020
Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel DiseaseR Kalla, A T Adams, N T Ventham, et al.
Clinical and Experimental Gastroenterology|February 19, 2019
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcomeChristine Olbjørn, Milada Cvancarova Småstuen, Espen Thiis-Evensen, et al.
Frontiers in Oncology|March 12, 2019
Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and ParagangliomaAbhishek Jha, Kristine de Luna, Charlene Ann Balili, et al.
Frontiers in Immunology|September 2, 2025
An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn's disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytesAndrew Yung Fong Li Yim, Ishtu Hageman, Vincent W Joustra, et al.
The Lancet. Oncology|August 15, 2015
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trialHarry D Bear, Gong Tang, Priya Rastogi, et al.
The New England Journal of Medicine|January 27, 2012
Bevacizumab added to neoadjuvant chemotherapy for breast cancerHarry D Bear, Gong Tang, Priya Rastogi, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
Cell Stem Cell|September 29, 2020
Loss of Extreme Long-Range Enhancers in Human Neural Crest Drives a Craniofacial DisorderHannah K Long, Marco Osterwalder, Ian C Welsh, et al.
Annals of Surgical Oncology|November 20, 2016
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40Harry D Bear, Gong Tang, Priya Rastogi, et al.
Endocrine-Related Cancer|September 29, 2016
Novel insights into the polycythemia-paraganglioma-somatostatinoma syndromeRoland Därr, Joan Nambuba, Jaydira Del Rivero, et al.
Pageof 93